[skip vbump] 583 Prepare release August 2023

DESCRIPTION

@@ -1,8 +1,8 @@
 Type: Package
 Package: chevron
 Title: Standard TLGs for Clinical Trials Reporting
-Version: 0.2.0.9034
-Date: 2023-07-19
+Version: 0.2.1
+Date: 2023-07-21
 Authors@R: c(
     person("Benoit", "Falquet", , "benoit.falquet@roche.com", role = c("aut", "cre")),
     person("Liming", "Li", , "liming.li@roche.com", role = "aut"),
@@ -19,20 +19,20 @@ Depends:
 Imports:
     checkmate (>= 2.0),
     dplyr,
-    dunlin (>= 0.1.3),
+    dunlin (>= 0.1.4),
     forcats (>= 1.0.0),
-    formatters (>= 0.5.0),
+    formatters (>= 0.5.1),
     ggplot2 (>= 3.4.0),
     glue,
     magrittr,
     methods,
     nestcolor (>= 0.1.1),
     purrr,
     rlang,
-    rlistings (>= 0.2.2),
-    rtables (>= 0.6.1),
+    rlistings (>= 0.2.3),
+    rtables (>= 0.6.2),
     stringr,
-    tern (>= 0.8.4),
+    tern (>= 0.8.5),
     tibble,
     utils
 Suggests:

NEWS.md

@@ -1,16 +1,20 @@
-# chevron 0.2.0.9034
+# chevron 0.2.1
 
+* Placeholder strings are now replaced during layout creation using `dunlin::render_safe` function.
+* New `chevron_catalog` vignette details usage and version of chevron templates.
+* The `run` method renders the errors faster thanks to the new internal `do_call` function.
 * Add `verbose` argument for `run` method which would print the argument used.
 * Add `row_split_var` and `page_var` as argument for some template.
-* Update `LBT06` template to use `PARAM` as row split.
-* Convert `AVISIT` to factor according to `AVISITN` as order in preprocessing.
-* Add `CFBT01` template. `VST01`, `EGT01` and `LBT01` are now all following `CFBT01`. By default parameters are by page displayed.
+* The `dataset` slot in `chevron_tlg` class has been removed.
+* Add `CFBT01` template. `VST01`, `EGT01` and `LBT01` are now all following `CFBT01`. By default parameters are displayed by page .
 * Add `RMPT03`, `RMPT04` and `RMPT05` which follow `RMPT01`.
+* Add `COXT01` template. `COXT02` is now based on `COXT01`.
+* Add `AET05` and `AET05_ALL` templates.
+* Add `LBT15` based on `LBT04`. `LBT04` has new arguments to make it more flexible.
 * Update `EGT03` to use `ACTARMCD` as default arm variable, and remove the preprocessing of filtering to "HR".
 * Update `EXT01` to allow it to be displayed by `PARCAT2`.
-* Add `COXT01` template. `COXT02` is based on `COXT01` now.
-* Add `AET05` and `AET05_ALL` template.
-* Add `LBT15` based on `LBT04`.
+* Update `LBT06` template to use `PARAM` as row split.
+* Convert `AVISIT` to factor and order levels according to `AVISITN` in preprocessing.
 * Update `MNG01` so that the numeric `jitter` argument controls the width of data spread along the x-axis.
 
 # chevron 0.2.0
@@ -31,7 +35,7 @@
 * Add more templates: `AET01_AESI`, `EGT03`, `EGT05_QTCAT`, `LBT04`, `LBT05`, `LBT07`, `LBT14`, `PDT01`, `PDT02`.
 * Deprecation of previous `getter` function like `get_main` to `main` and `main<-`.
 * Add `chevron_t`, `chevron_l` and `chevron_g` subclass of `chevron_tlg`.
 * Add `script_funs` and `script_args` to obtain string representation of the full code.
 * Update to current templates.
 
 # chevron 0.1.2

README.md

@@ -23,11 +23,11 @@
 
 <!-- markdownlint-enable MD033 -->
 
-`chevron` is a collection of function to create standard tables, listings, and graphs for clinical trials reporting.
+`chevron` is a collection of functions to create standard tables, listings, and graphs for clinical trials reporting.
 
 ## Installation
 
 It is recommended that you [create and use a GitHub PAT](https://docs.github.com/en/github/authenticating-to-github/keeping-your-account-and-data-secure/creating-a-personal-access-token) to install the latest version of this package. Once you have the PAT, run the following:
 
 ```r
 Sys.setenv(GITHUB_PAT = "your_access_token_here")
@@ -48,10 +48,10 @@
 
 ```text
   MedDRA System Organ Class                                     A: Drug X    B: Placebo    C: Combination
     MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)    
   ———————————————————————————————————————————————————————————————————————————————————————————————————————
   Total number of patients with at least one adverse event     122 (91.0%)   123 (91.8%)    120 (90.9%)  
   Overall total number of events                                   609           622            703      
   cl A.1                                                                                                 
     Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)  
     Total number of events                                         132           130            160